| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 127, 3070-3078, Copyright © 1990 by Endocrine Society
ARTICLES |
T Takao, DE Tracey, WM Mitchell and EB De Souza
Neurobiology Laboratory, National Institute on Drug Abuse, Addiction Research Center, Baltimore, Maryland 21224.
The cytokine interleukin-1 (IL-1) has a variety of effects in brain, including induction of fever, alteration of slow wave sleep, and alteration of neuroendocrine activity. To examine the potential sites of action of IL-1 in brain, we used iodine-125-labeled recombinant human interleukin-1 [( 125I]IL-1) to identify and characterize IL-1 receptors in crude membrane preparations of mouse (C57BL/6) hippocampus and to study the distribution of IL-1-binding sites in brain using autoradiography. In preliminary homogenate binding and autoradiographic studies, [125I]IL-1 alpha showed significantly higher specific binding than [125I]IL-1 beta. Thus, [125I]IL-1 alpha was used in all subsequent assays. The binding of [125I]IL-1 alpha was linear over a broad range of membrane protein concentrations, saturable, reversible, and of high affinity, with an equilibrium dissociation constant value of 114 +/- 35 pM and a maximum number of binding sites of 2.5 +/- 0.4 fmol/mg protein. In competition studies, recombinant human IL-1 alpha, recombinant human IL-1 beta, and a weak IL-1 beta analog. IL-1 beta +, inhibited [125I]IL-1 alpha binding to mouse hippocampus in parallel with their relative bioactivities in the T-cell comitogenesis assay, with inhibitory binding affinity constants of 55 +/- 18, 76 +/- 20, and 2940 +/- 742 pM, respectively; rat/human CRF and human tumor necrosis factor showed no effect on [125I]IL-1 alpha binding. Autoradiographic localization studies revealed very low densities of [125I]IL-1 alpha- binding sites throughout the brain, with highest densities present in the molecular and granular layers of the dentate gyrus of the hippocampus and in the choroid plexus. Quinolinic acid lesion studies demonstrated that the [125I]IL-1 alpha-binding sites in the hippocampus were localized to intrinsic neurons. After hypophysectomy, homogenate binding and autoradiographic studies showed that there was no apparent change in the relative density of IL-1 receptors in the hippocampus. The identification of IL-1 receptors in brain with characteristics similar to IL-1 receptors in immune and neuroendocrine tissues provides further support for a physiological role for IL-1 to regulate central nervous system activity.
This article has been cited by other articles:
![]() |
K. Kagiwada, D. Chida, T. Sakatani, M. Asano, A. Nambu, S. Kakuta, and Y. Iwakura Interleukin (IL)-6, But Not IL-1, Induction in the Brain Downstream of Cyclooxygenase-2 Is Essential for the Induction of Febrile Response against Peripheral IL-1{alpha} Endocrinology, November 1, 2004; 145(11): 5044 - 5048. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vezzani, M. Conti, A. De Luigi, T. Ravizza, D. Moneta, F. Marchesi, and M. G. De Simoni Interleukin-1beta Immunoreactivity and Microglia Are Enhanced in the Rat Hippocampus by Focal Kainate Application: Functional Evidence for Enhancement of Electrographic Seizures J. Neurosci., June 15, 1999; 19(12): 5054 - 5065. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cartmell, T. Southgate, G. S. Rees, M. G. Castro, P. R. Lowenstein, and G. N. Luheshi Interleukin-1 Mediates a Rapid Inflammatory Response After Injection of Adenoviral Vectors into the Brain J. Neurosci., February 15, 1999; 19(4): 1517 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Murray and M. A. Lynch Evidence That Increased Hippocampal Expression of the Cytokine Interleukin-1beta Is a Common Trigger for Age- and Stress-Induced Impairments in Long-Term Potentiation J. Neurosci., April 15, 1998; 18(8): 2974 - 2981. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cremona, E. Goujon, K. W. Kelley, R. Dantzer, and P. Parnet Brain type I but not type II IL-1 receptors mediate the effects of IL-1beta on behavior in mice Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R735 - R740. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, F. C. Barone, N. V. Aiyar, G. Z. Feuerstein, and G. J. del Zoppo Interleukin-1 Receptor and Receptor Antagonist Gene Expression After Focal Stroke in Rats Stroke, January 1, 1997; 28(1): 155 - 162. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |